These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 6661886)
1. [Behavior of platelet aggregation during therapy with nifedipine]. Lenci R; Galante A; Borzi M; Ariganello M; Sommariva L; Pino M; Cannata D Clin Ter; 1983 Dec; 107(5):371-4. PubMed ID: 6661886 [No Abstract] [Full Text] [Related]
2. [Platelet aggregation in patients with coronary disease treated with nifedipine]. Tkaczewski W; Goch JH; Kruszyński G; Ryniec A Pol Tyg Lek; 1990 Mar 5-12; 45(10-11):219-21. PubMed ID: 2216944 [TBL] [Abstract][Full Text] [Related]
3. [Oxprenol and platelet aggregation (author's transl)]. Risica G; Benzoni A; Zagatti G; Caturelli G G Ital Cardiol; 1978 May; 8(5):496-502. PubMed ID: 669107 [TBL] [Abstract][Full Text] [Related]
4. [Preliminary studies of the effect of nifedipine on platelet aggregation induced with ADP]. Campa PP; Di Michele D; Paparoni S; De Curtis G; Moschetta D Boll Soc Ital Cardiol; 1980; 25(3):225-30. PubMed ID: 7284127 [No Abstract] [Full Text] [Related]
5. [Effect of nifedipine on platelet aggregation due to ADP in the course of propranolol infusion]. Di Michele D; Paparoni S; Moschetta D; De Curtis G; Campa PP Boll Soc Ital Cardiol; 1981; 26(12):2245-6. PubMed ID: 7185394 [No Abstract] [Full Text] [Related]
6. [The effect of long-term therapy with a calcium antagonist on thrombocyte function in hypertension patients]. Baliakina EV; Atakhanov ShE; Gabbasov ZA; Popov EG; Iurenev AP Ter Arkh; 1992; 64(8):39-43. PubMed ID: 1440393 [No Abstract] [Full Text] [Related]
7. [ADP-induced thrombocyte aggregation in vitro in patients with ischemic heart disease and peripheral thrombo-arteriosclerosis]. Gormsen J; Agerskov Andersen L; Dalsgaard Nielsen J Ugeskr Laeger; 1977 Aug; 139(34):2003-7. PubMed ID: 906116 [No Abstract] [Full Text] [Related]
8. [Effect of graduated doses of nifedipine on ADP-induced platelet aggregation]. Campa PP; Di Michele D; Paparoni S; De Curtis G; Fraioli A Boll Soc Ital Cardiol; 1980; 25(8):963-4. PubMed ID: 7284187 [No Abstract] [Full Text] [Related]
9. [Various aspects of the anti-aggregatory action of diltiazem and cordaphene in patients with ischemic heart disease]. Leonova MV; Rumiantsev DO; Belousov IuB Kardiologiia; 1991 Mar; 31(3):13-6. PubMed ID: 1875587 [TBL] [Abstract][Full Text] [Related]
10. [A method for determining individual nifedipine sensitivity in treating hypertension patients]. Baliakina EV; Atakhanov ShE; Gabbasov ZA; Popov EG; Iurenev AP Ter Arkh; 1993; 65(12):19-22. PubMed ID: 8146764 [TBL] [Abstract][Full Text] [Related]
11. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation. Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373 [TBL] [Abstract][Full Text] [Related]
12. Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy). Serebruany VL; Malinin AI; O'connor CM; Gurbel PA; Am Heart J; 2003 Jul; 146(1):91-8. PubMed ID: 12851613 [TBL] [Abstract][Full Text] [Related]
13. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. von Beckerath N; Taubert D; Pogatsa-Murray G; Schömig E; Kastrati A; Schömig A Circulation; 2005 Nov; 112(19):2946-50. PubMed ID: 16260639 [TBL] [Abstract][Full Text] [Related]
14. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease]. Wlazłowski R; Kruszyński G; Goch JH Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734 [TBL] [Abstract][Full Text] [Related]
15. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes. Mitsios JV; Papathanasiou AI; Elisaf M; Goudevenos JA; Tselepis AD Platelets; 2005 Aug; 16(5):287-92. PubMed ID: 16011979 [TBL] [Abstract][Full Text] [Related]
16. [Characteristics of the initial stage of ADP-induced thrombocyte aggregation in ischemic heart disease]. Gorbachev VV; Samal' AB; Khapaliuk AV; Cherenkevich SN Lab Delo; 1982; (5):278-80. PubMed ID: 6178882 [No Abstract] [Full Text] [Related]
17. Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target. Gurbel PA; Antonino MJ; Bliden KP; Dichiara J; Suarez TA; Singla A; Tantry US Platelets; 2008 Dec; 19(8):595-604. PubMed ID: 19012177 [TBL] [Abstract][Full Text] [Related]
18. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry. Bauriedel G; Skowasch D; Schneider M; Andrié R; Jabs A; Lüderitz B Am Heart J; 2003 Feb; 145(2):343-8. PubMed ID: 12595854 [TBL] [Abstract][Full Text] [Related]
19. Effect of Ca2+-antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil, on platelet aggregation in vitro. Ono H; Kimura M Arzneimittelforschung; 1981; 31(7):1131-4. PubMed ID: 7196762 [TBL] [Abstract][Full Text] [Related]
20. [Effect of nifedipine on platelet function]. Hu ZW Zhonghua Xin Xue Guan Bing Za Zhi; 1986 Jun; 14(3):145-6. PubMed ID: 3780394 [No Abstract] [Full Text] [Related] [Next] [New Search]